A phase I study of an oral formulation of ixabepilone (ixa) in patients with advanced cancer.
2010 ◽
Vol 28
(15_suppl)
◽
pp. e13090-e13090
2018 ◽
Vol 24
(8)
◽
pp. 1816-1823
◽
2008 ◽
Vol 14
(21)
◽
pp. 7127-7137
◽
2004 ◽
Vol 22
(14_suppl)
◽
pp. 3141-3141